- Filed
- Aug 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 14, 2024 | 14.82M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $3.61M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $4.36M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $5.26M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $8.69M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $9.39M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $12.53M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $16.32M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $21.67M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $47.1M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $51.35M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 16.69M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 16.56M sh |
| Stock Repurchased | Q2 2024 · Jun 30, 2023 | $0 |
| Capex | Q2 2024 · Jun 30, 2023 | $695.83K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$364.12K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $38.18M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $36.53M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $34.54M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.10 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.09 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.11 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.10 |
| Net Income | Q2 2024 · Jun 30, 2023 | $1.66M |
| Net Income | Q2 2024 · Jun 30, 2023 | $1.52M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$141.74K |
| Operating Income | Q2 2024 · Jun 30, 2023 | $2.37M |
| Operating Income | Q2 2024 · Jun 30, 2023 | $2.27M |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $5.64M |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $11.28M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $6.89M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $13.7M |
| Revenue | Q2 2024 · Jun 30, 2023 | $12.52M |
| Revenue | Q2 2024 · Jun 30, 2023 | $24.98M |